Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

DMSO-free Cryopreservation Solution for MSCs

November 24, 2014 2:18 pm | Product Releases | Comments

PRIME-XV FreezIS DMSO-Free from Irvine Scientific is a chemically-defined cryopreservation solution for human mesenchymal stem/stromal cells (MSCs) that is free of dimethyl sulfoxide (DMSO) and animal-derived components.

Software Simplifies SPE Processes

November 24, 2014 2:07 pm | Product Releases | Comments

The SmartPrep Version 2 from Horizon Technology is a validated software for the SmartPrep Extractor, a cartridge-based solid phase extraction (SPE) system. 

TOPICS:

Amgen ends studies of gastric cancer drug

November 24, 2014 1:58 pm | by The Associated Press | News | Comments

Biotech drugmaker Amgen said Monday it is ending late-stage trials of its gastric cancer treatment rilotumumab because patients who took the drug were more likely to die. Amgen said more patients died after treatment with rilotumumab and chemotherapy than with chemotherapy alone. The company said...

Advertisement

Merck, Iowa Firm Sign Ebola Vaccine Licensing Deal

November 24, 2014 1:58 pm | by Linda A. Johnson - AP Business Writer - Associated Press | News | Comments

Merck & Co., a top creator and seller of vaccines, has joined the fight against Ebola, the often-fatal hemorrhagic virus that's been ravaging parts of West Africa for months.                     

TOPICS:

Exciting Gains in Fighting Breast Cancer Hormone-therapy Resistance

November 24, 2014 1:56 pm | by Cynthia Fox, Science Writer | Articles | Comments

Guided by breakthrough research on the Estrogen Receptor 1 (ESR1) gene, many researchers and pharmaceutical companies are in hot pursuit of the next big anti-resistance breast cancer drug.                  

TOPICS:

Computer Games Could Prevent Falls in the Elderly

November 24, 2014 12:22 pm | News | Comments

A research team has developed new computer games designed to significantly reduce the likelihood of falls at home and in the community among older people.                            

TOPICS:

Test Detects Early Brain Damage in Football Players

November 24, 2014 12:12 pm | News | Comments

A new, enhanced MRI diagnostic approach was, for the first time, able to identify significant damage to the blood-brain barrier (BBB) of professional football players following “unreported” trauma or mild concussions.          

TOPICS:

Tiny Patient Prompts Advance in Neurogenetics

November 24, 2014 11:54 am | News | Comments

Researchers had never shown exactly how cells in the brain stem detect carbon dioxide and regulate breathing in humans. After taking a mutation from a two-month-old baby and expressing it in human astrocytes, they did exactly that, and the research may lead to an early warning system to save premature infants.

TOPICS:
Advertisement

Schizophrenia May be Triggered by Excess Protein

November 24, 2014 11:18 am | News | Comments

A gene associated with schizophrenia plays a role in brain development and may help to explain the biological process of the disease, according to new research.                          

TOPICS:

Italian doctor with Ebola returning for treatment

November 24, 2014 7:57 am | by The Associated Press | News | Comments

The Italian health ministry says an Italian doctor working in Sierra Leone has tested positive for the Ebola virus and is being transferred to Rome for treatment. The ministry said in a statement Monday that the doctor, who works for the non-governmental organization Emergency, is arriving...

Liberia free of Ebola by Christmas, says president

November 24, 2014 7:57 am | by Jonathan Paye-layleh - Associated Press - Associated Press | News | Comments

Liberia's president on Monday urged her countrymen to double their efforts to reach the government's goal of having zero new Ebola cases by Dec. 25, a target some experts have described as highly ambitious. "We've set a pretty tough target. But when you set a target it means that you stay focused...

BioMarin Pharma offers about $680M for Prosensa

November 24, 2014 7:57 am | by The Associated Press | News | Comments

BioMarin Pharmaceutical will pay $680 million in cash for the Dutch biotech company Prosensa in a bid to strengthen its pipeline of genetic disorder treatments. The San Rafael, California, company also said it will make two approximately $80 million milestone payments to Prosensa shareholders if...

Health Care M&A Leads Global Deal Surge

November 23, 2014 6:57 pm | by Linda A. Johnson and Steve Rothwell - AP Business Writers - Associated Press | News | Comments

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates are also fueling the mergers and acquisitions.

TOPICS:

U.S. Looking Past Ebola to Prepare for Next Outbreak

November 23, 2014 8:57 am | by Lauran Neergaard - AP Medical Writer - Associated Press | News | Comments

The next Ebola or the next SARS. Maybe even the next HIV. Even before the Ebola epidemic in West Africa is brought under control, public health officials are girding for the next health disaster.               

TOPICS:

Search continues at ancient Greek burial mound

November 22, 2014 3:57 pm | by Costas Kantouris - Associated Press - Associated Press | News | Comments

Scientists have opened the second phase of their excavation of the vast 4th-century BC burial mound in Amphipolis town in search of more tombs and bodies. The first search of the site, which was built shortly after Alexander the Great's death, discovered and dug up a tomb containing a skeleton. ...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading